Edelweiss cancer Open Access is interested in publishing research, review manuscripts covering all aspects of cancer. We invite manuscripts which are novel and highly innovative in detecting or curing cancer of all forms. Clinical trial studies, research on new therapeutic agents, drugs and chemicals and new concepts for detection and treatment of cancer.
Cancer Open Access Journal uses online submission, review and tracking of the manuscript for quality and the quick review process.
Edelweiss Publications uses Manuscript Manager System, an online submission and review system, a platform for Editors, Reviewers, authors and publishers at one place, developed indigenously by Edelweiss Publications. MM system helps author to submit their articles and track its progress, as well Editor and Reviewers will be able to download manuscripts and submit their opinions/Comments. It also provides editors authority to give their final decision on the manuscript.
Manuscript number will be allocated and communicated to the corresponding author within 48 hours for the manuscript submitted. 3 weeks of rapid review process adhering to international peer-review standards. Timeline of processing from Submission to Publication is 45 days.
Cancer Open Access welcome submissions related to above fields. Authors may submit their valuable work at: firstname.lastname@example.org or email@example.com